{{Drugbox
| IUPAC_name = (((4,5Î±-Epoxy-3-methoxy-17-methylmorphinan-6-ylidene)amino)oxy)acetic acid
| image = Codoxime.svg
| width = 220

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule I
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US =  
| legal_UN = N I
| legal_DE = Anlage I
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 7125-76-0
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 9570253
| DrugBank =  
| ChEMBL = 2107300
| ChemSpiderID = 7844721
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = JT5I2F57F7
| KEGG = D03581

<!--Chemical data-->
| C=20 | H=24 | N=2 | O=5 
| molecular_weight = 372.415 g/mol
| smiles = O=C(O)CO\N=C4\[C@@H]5Oc1c2c(ccc1OC)C[C@H]3N(CC[C@]25[C@H]3CC4)C
| synonyms = Codoxime
}}

'''Codoxime''' ('''Codossima''') is an [[opiate]] analogue that is a derivative of [[hydrocodone]], where the 6-[[ketone]] group has been replaced by carboxymethyloxime. It has primarily [[antitussive]] effects<ref>[http://www.google.com/patents?id=1epzAAAAEBAJ&dq=3153042 Jack Fishman. Morphinone and Codeinone Derivatives. US Patent 3153042]</ref> and was found to have moderate potential to cause dependence in animal studies.<ref>Jasinski DR, Martin WR. Assessment of the dependence-producing properties of dihydrocodeinone and codoxime. ''Clinical Pharmacology and Therapeutics''. 1967 Mar-Apr;8(2):266-70. {{PMID|6021586}}</ref>

==References==
{{Reflist|2}}


{{Opioidergics}}

[[Category:Antitussives]]
[[Category:Morphinans]]
[[Category:Phenol ethers]]
[[Category:Mu-opioid agonists]]
[[Category:Semisynthetic opioids]]


{{analgesic-stub}}